Correlation Between Centessa Pharmaceuticals and Morgan Stanley
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Morgan Stanley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Morgan Stanley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Morgan Stanley, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Morgan Stanley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Morgan Stanley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Morgan Stanley.
Diversification Opportunities for Centessa Pharmaceuticals and Morgan Stanley
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Centessa and Morgan is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Morgan Stanley in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Morgan Stanley and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Morgan Stanley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Morgan Stanley has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Morgan Stanley go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Morgan Stanley
Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 3.92 times more return on investment than Morgan Stanley. However, Centessa Pharmaceuticals is 3.92 times more volatile than Morgan Stanley. It trades about 0.07 of its potential returns per unit of risk. Morgan Stanley is currently generating about -0.23 per unit of risk. If you would invest 1,610 in Centessa Pharmaceuticals PLC on September 19, 2024 and sell it today you would earn a total of 65.00 from holding Centessa Pharmaceuticals PLC or generate 4.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Morgan Stanley
Performance |
| Timeline |
| Centessa Pharmaceuticals |
| Morgan Stanley |
Centessa Pharmaceuticals and Morgan Stanley Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Centessa Pharmaceuticals and Morgan Stanley
The main advantage of trading using opposite Centessa Pharmaceuticals and Morgan Stanley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Morgan Stanley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Morgan Stanley will offset losses from the drop in Morgan Stanley's long position.The idea behind Centessa Pharmaceuticals PLC and Morgan Stanley pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Morgan Stanley vs. Scully Royalty | Morgan Stanley vs. Mercurity Fintech Holding | Morgan Stanley vs. Donnelley Financial Solutions | Morgan Stanley vs. CreditRiskMonitorCom |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |